{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:48:22Z","timestamp":1761630502496},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2375,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1111\/j.1365-2133.2008.08978.x","type":"journal-article","created":{"date-parts":[[2008,12,18]],"date-time":"2008-12-18T02:44:23Z","timestamp":1229568263000},"page":"687-691","source":"Crossref","is-referenced-by-count":23,"title":["First experience with enteric-coated mycophenolate sodium (Myfortic<sup>\u00ae<\/sup>) in severe recalcitrant adult atopic dermatitis: an open label study"],"prefix":"10.1093","volume":"160","author":[{"given":"S.G.A.","family":"van Velsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.M.","family":"Haeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.A.F.M.","family":"Bruijnzeel-Koomen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.","family":"de Bruin-Weller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0190-9622(94)70004-4","article-title":"The prevalence of childhood atopic eczema in a general population","volume":"30","author":"Kay","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Schacke","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2133.1997.tb08750.x","article-title":"Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis","volume":"136","author":"Berth-Jones","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0140-6736(91)90134-B","article-title":"Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis","volume":"338","author":"Sowden","year":"1991","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1468-3083.2006.01877.x","article-title":"Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis","volume":"21","author":"Hijnen","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2310\/6620.2007.06025","article-title":"Cyclosporin A treatment is associated with increased serum immunoglobulin E levels in a subgroup of atopic dermatitis patients","volume":"18","author":"Hijnen","year":"2007","journal-title":"Dermatitis"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB7","first-page":"870","article-title":"Mycophenolate mofetil is effective in the treatment of atopic dermatitis","volume":"137","author":"Grundmann-Kollmann","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB8","first-page":"23","article-title":"Mycophenolate mofetil therapy for moderate to severe atopic dermatitis","volume":"32","author":"Murray","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2133.2000.03667.x","article-title":"Treatment of atopic eczema with oral mycophenolate mofetil","volume":"143","author":"Neuber","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2165\/00002018-200124090-00002","article-title":"Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management","volume":"24","author":"Behrend","year":"2001","journal-title":"Drug Saf"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB11","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2165\/00003495-200565080-00001","article-title":"Enteric-coated mycophenolate sodium: tolerability profile compared with mycophenolate mofetil","volume":"65","author":"Behrend","year":"2005","journal-title":"Drugs"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1600-6143.2003.00321.x","article-title":"Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study","volume":"4","author":"Budde","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1600-6143.2003.00337.x","article-title":"Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients","volume":"4","author":"Salvadori","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0190-9622(18)30747-3","article-title":"Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses","volume":"37","author":"Kitchin","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB15","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1021\/cr990097b","article-title":"Mycophenolic acid: a one hundred year odyssey from antibiotic to immunosuppressant","volume":"100","author":"Bentley","year":"2000","journal-title":"Chem Rev"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2008.08978.x-BIB16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic dermatitis","volume":"92","author":"Hanifin","year":"1980","journal-title":"Acta Derm Venereal (Stockh)"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB17","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1600-6143.2006.01693.x","article-title":"Pharmacokinetic and pharmacodynamic comparison of enteric-coated mycophenolate sodium and mycophenolate mofetil in maintenance renal transplant patients","volume":"7","author":"Budde","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000245677","article-title":"Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis","volume":"195","author":"Kunz","year":"1997","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0738-081X(02)00368-1","article-title":"The use of corticosteroids and corticosteroid phobia in atopic dermatitis","volume":"21","author":"Charman","year":"2003","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jaci.2003.12.007","article-title":"Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis","volume":"113","author":"Hijnen","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1468-3083.2006.02023.x","article-title":"Cyclosporin in the treatment of patients with atopic eczema-a systematic review and meta-analysis","volume":"21","author":"Schmitt","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB22","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.transproceed.2006.08.085","article-title":"Renal transplant patients with gastrointestinal intolerability to mycophenolate mofetil: conversion to enteric-coated mycophenolate sodium","volume":"38","author":"Calvo","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2133.1999.02952.x","article-title":"Successful treatment of severe refractory atopic dermatitis with mycophenolate mofetil","volume":"141","author":"Grundmann-Kollmann","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08978.x-BIB24","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.transproceed.2007.03.064","article-title":"Efficacy and safety of enteric-coated mycophenolate sodium in de novo renal transplant recipients: pooled data from three 12-month multicenter, open-label, prospective studies","volume":"39","author":"Legendre","year":"2007","journal-title":"Transplant Proc"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2008.08978.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2008.08978.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T05:48:32Z","timestamp":1709790512000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/160\/3\/687\/6641656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08978.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}